The obesity drug developer Metsera said on Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of the weight-loss treatments Ozempic and Wegovy.
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
nyti.ms
November 8, 2025 at 8:25 PM
The obesity drug developer Metsera said on Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of the weight-loss treatments Ozempic and Wegovy.
Pfizer wins early US approval of bid to take over obesity biotech Metsera ft.trib.al/FLccnU8
Pfizer wins early US approval of bid to take over obesity biotech Metsera
Move is a sign Washington may intervene in dramatic public battle with Novo Nordisk over coveted weight loss start-up
ft.trib.al
October 31, 2025 at 8:41 PM
Pfizer wins early US approval of bid to take over obesity biotech Metsera ft.trib.al/FLccnU8
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports reut.rs/3VNtHa5
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports
Pfizer is closing in on a potential $7.3 billion takeover of weight-loss drug developer Metsera , the Financial Times reported on Sunday, citing unidentified sources.
reut.rs
September 22, 2025 at 5:00 AM
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports reut.rs/3VNtHa5
Pfizer wins $10bn bidding war for weight-loss start-up Metsera on.ft.com/4hONr7f
Pfizer wins $10bn bidding war for weight-loss start-up Metsera
Biotech says it opted for revised offer from US pharma company after rival Novo bid raised antitrust concerns
on.ft.com
November 8, 2025 at 3:53 AM
Pfizer wins $10bn bidding war for weight-loss start-up Metsera on.ft.com/4hONr7f
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.
bit.ly
November 9, 2025 at 5:30 AM
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.
Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera ft.trib.al/GJNb5uR
Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera
Pfizer had struck deal in September to buy obesity-focused biotech
ft.trib.al
October 30, 2025 at 4:23 PM
Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera ft.trib.al/GJNb5uR
Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera on.ft.com/3Kf0Qsr
Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera
Deal is the biggest by a large pharma company buying a foothold in the lucrative and fast-growing market
on.ft.com
September 22, 2025 at 11:41 AM
Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera on.ft.com/3Kf0Qsr
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports reut.rs/4oRbkgA
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Pfizer has submitted a sweetened bid for obesity drug developer Metsera , as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday.
reut.rs
November 8, 2025 at 1:10 AM
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports reut.rs/4oRbkgA
Pfizer has agreed to buy weight-loss startup Metsera in a deal that could be worth more than $10 billion, outbidding rival Novo Nordisk
Breaking | Pfizer and Metsera Reach Deal Expected to Top $10 Billion
Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup.
on.wsj.com
November 8, 2025 at 3:24 AM
Pfizer has agreed to buy weight-loss startup Metsera in a deal that could be worth more than $10 billion, outbidding rival Novo Nordisk
Pfizer sues Metsera, Novo Nordisk over breach of merger deal reut.rs/47PMsAd
Pfizer sues Metsera, Novo Nordisk over breach of merger deal
Pfizer on Friday filed a lawsuit against Metsera and Novo Nordisk , accusing them of breaking a merger agreement and interfering with the deal.
reut.rs
October 31, 2025 at 8:50 PM
Pfizer sues Metsera, Novo Nordisk over breach of merger deal reut.rs/47PMsAd
Pfizer gets US antitrust clearance for Metsera deal reut.rs/4ntHg9J
Pfizer gets US antitrust clearance for Metsera deal
Pfizer said on Friday it has received an early clearance from the U.S. Federal Trade Commission for its proposed acquisition of Metsera , removing a key regulatory hurdle for the deal valued at up to $7.3 billion.
reut.rs
October 31, 2025 at 8:05 PM
Pfizer gets US antitrust clearance for Metsera deal reut.rs/4ntHg9J
There’s a rapidly intensifying battle underway for Metsera, a three-year-old obesity startup working on experimental treatments in one of the hottest areas in medicine
Novo Locks Horns With Pfizer Over Obesity Startup Metsera
Contest has sparked a hot bidding war and a court battle.
bloom.bg
November 7, 2025 at 11:30 AM
There’s a rapidly intensifying battle underway for Metsera, a three-year-old obesity startup working on experimental treatments in one of the hottest areas in medicine
Novo Nordisk Mike Doustdar lost out to Pfizer in a $10 billion takeover battle for obesity drug developer Metsera, but he's keeping deals on the table as the Danish company seeks to regain lost ground in the booming weight-loss market.
Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer
Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover battle for obesity drug developer Metsera Inc. But don’t expect him to give up on dealmaking any time soon as the Danish company seeks to regain lost ground in the booming weight-loss market.
bloom.bg
November 8, 2025 at 10:30 PM
Novo Nordisk Mike Doustdar lost out to Pfizer in a $10 billion takeover battle for obesity drug developer Metsera, but he's keeping deals on the table as the Danish company seeks to regain lost ground in the booming weight-loss market.
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial reut.rs/43y9V74
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a monthly dosing regime.
reut.rs
June 9, 2025 at 4:15 PM
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial reut.rs/43y9V74
Pfizer has filed a second lawsuit against Metsera and Novo Nordisk, alleging the weight-loss drug developers’ recent merger agreement would violate federal antitrust laws.
Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera
Lawsuit says the proposed merger of the weight-loss drugmakers could kill off a smaller competitor.
on.wsj.com
November 3, 2025 at 2:54 PM
Pfizer has filed a second lawsuit against Metsera and Novo Nordisk, alleging the weight-loss drug developers’ recent merger agreement would violate federal antitrust laws.
I was literally writing a blog post on this - TrumpRX and whether it would affect Novo's bid for Metsera - when this popped up, so ... thanks for that:
www.businesslawprofessors.com/2025/11/side...
www.businesslawprofessors.com/2025/11/side...
November 6, 2025 at 8:44 PM
I was literally writing a blog post on this - TrumpRX and whether it would affect Novo's bid for Metsera - when this popped up, so ... thanks for that:
www.businesslawprofessors.com/2025/11/side...
www.businesslawprofessors.com/2025/11/side...
Novo Nordisk raises its bid again for obesity-drug startup Metsera, pushing the takeover battle with Pfizer toward a final showdown as both pharma giants race to dominate a $100B weight-loss market.
November 6, 2025 at 9:02 PM
Novo Nordisk raises its bid again for obesity-drug startup Metsera, pushing the takeover battle with Pfizer toward a final showdown as both pharma giants race to dominate a $100B weight-loss market.
They are "dropping the price" of the obesity drugs because Pfizer and Novo are in a bidding war for Metsera and if Novo wins it will essentially have a monopoly...
November 6, 2025 at 9:27 PM
They are "dropping the price" of the obesity drugs because Pfizer and Novo are in a bidding war for Metsera and if Novo wins it will essentially have a monopoly...
Just 1 month after Pfizer agreed to buy obesity biotech firm Metsera, Ozempic developer Novo Nordisk has put in an unsolicited rival bid to acquire the company, throwing the original agreement into question. cen.acs.org/business/mer... #chemsky 🧪
Novo Nordisk makes a play for obesity biotech, challenging Pfizer deal
Danish drugmaker launches unsolicited bid to acquire weight-loss-drug developer Metsera
cen.acs.org
November 2, 2025 at 10:29 AM
Just 1 month after Pfizer agreed to buy obesity biotech firm Metsera, Ozempic developer Novo Nordisk has put in an unsolicited rival bid to acquire the company, throwing the original agreement into question. cen.acs.org/business/mer... #chemsky 🧪
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up reut.rs/3Lff2T3
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Novo Nordisk and Pfizer have revised their bids for Metsera , the obesity drug developer said on Tuesday.
reut.rs
November 4, 2025 at 2:35 PM
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up reut.rs/3Lff2T3
Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial reut.rs/4v1FiSU
Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial
Pfizer presented data on Saturday that showed a monthly dose of an experimental obesity drug it acquired through its purchase of Metsera last year had a similar side-effect profile as rival Novo Nordisk's weekly injection Wegovy.
reut.rs
June 6, 2026 at 1:15 PM
Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial reut.rs/4v1FiSU
Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets it back into the burgeoning market for obesity drugs.
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion
The deal will get the drugmaker back into the burgeoning market for obesity drugs.
on.wsj.com
September 22, 2025 at 1:00 PM
Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets it back into the burgeoning market for obesity drugs.
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war? reut.rs/4ihSsFP
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder approval, securing a path into the fast-growing obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk.
reut.rs
November 13, 2025 at 5:35 PM
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war? reut.rs/4ihSsFP
Timely newsletters are crucial for effective decision-making and strategic planning. Keep up the great work, and I look forward to continuing our collaboration! www.bloomberg.com/opinion/news...
Pay Now, Merge Later
Metsera, Elon Musk’s pay package, fake receivables and AI performance reviews.
www.bloomberg.com
October 30, 2025 at 5:35 PM
Timely newsletters are crucial for effective decision-making and strategic planning. Keep up the great work, and I look forward to continuing our collaboration! www.bloomberg.com/opinion/news...
Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker's $8.5 billion bid for the U.S. obesity drug developer to be a superior offer.
October 31, 2025 at 9:53 PM
Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker's $8.5 billion bid for the U.S. obesity drug developer to be a superior offer.